Target: Stroke, launched in 2010 by the American Heart Association, was a quality improvement initiative aimed at helping stroke centers reduce their door-to-needle treatment times.
At the 2019 International Stroke Conference, the AHA released phase III, which will give facilities the ability to be recognized for their efforts of faster door-to-needle times while also giving first-ever goals for Endovascular Treatment. Facilities who meet the new Phase III requirements will have the ability to be recognized starting in 2020.
Does your facility have a plan for meeting the new phase III goals?
If not, Pulsara should be your answer! Did you know the #1 reason for delayed treatment is communication breakdown? At Pulsara, we pride ourselves on our ability to place entire teams on the same communication channel - which research shows decreases treatment times and can help reduce medical errors secondary to miscommunication.
For more information on Target: Stroke Phase III click HERETo find out how Pulsara can help YOU decrease treatment times at your facility and get you one step closer to meeting Target: Stroke Phase III Goals click HERE